Treatment of Immune Thrombocytopenic Purpura: Focus on Eltrombopag

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.2009.2984
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Dove Medical Press Ltd.

Related search

Immune Thrombocytopenic Purpura and Infections

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2018English

Eltrombopag Managed Severe Immune Thrombocytopenic Purpura in Pregnancy: A Case Report, Latifa Hospital, DHA, Dubai, UAE

Open Journal of Obstetrics and Gynecology
2019English

Molecular Mechanisms for Developing Immune Thrombocytopenic Purpura

Japanese Journal of Thrombosis and Hemostasis
2010English

Multiple Myeloma With Concurrent Immune Thrombocytopenic Purpura

ecancermedicalscience
Cancer ResearchOncology
2020English

Chronic Immune Thrombocytopenic Purpura—who Needs Medication?

Annals of Hematology
MedicineHematology
2010English

Coexistence of Immune Thrombocytopenic Purpura and Polycythemia Vera

Clinical Research and Trials
2019English

PP025 Thrombopoietin Receptor Agonist for Treatment of Adults With Chronic Immune Thrombocytopenic Purpura

International Journal of Technology Assessment in Health Care
Health Policy
2017English

Coexisting Situs Inversus Totalis and Immune Thrombocytopenic Purpura

Case Reports in Surgery
2016English

Does Helicobater Pylori Initiate or Perpetuate Immune Thrombocytopenic Purpura?

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy